State R&D Credits · Brief · Working level
Massachusetts R&D tax credit: two rates, its own mechanics, permanent
Massachusetts offers a permanent research credit — 10% on the incremental computation and 15% for basic research payments, with an alternative simplified-style election — subject to distinctive liability limitations and an unlimited carryforward for amounts blocked by the 75% rule.
Massachusetts pairs federal definitions with distinctly homegrown mechanics. As of mid-2026, the research credit is 10% of Massachusetts qualified research expenses over a base amount, 15% for basic research payments, with an elective alternative simplified-style computation — permanent law, claimed self-serve against the corporate excise, but metered by liability limitations found almost nowhere else. Verify current parameters with the Massachusetts Department of Revenue.
Computation: federal definitions, Massachusetts machine
Qualified research and QREs take their meaning from federal Section 41, restricted to research performed in Massachusetts — so the federal qualification file transfers, and the state work is sourcing and computation. Two computational paths exist as of mid-2026: the traditional incremental method (10% of in-state QREs over a fixed-base-style amount, plus 15% of basic research payments), and an elective alternative computation modeled on the federal ASC, keyed to a percentage of the excess over a portion of the prior three years' in-state QREs at a lower rate. That election matters for companies without workable base-period history — the same relief valve the federal ASC provides, which California conspicuously lacks. The dimension framework treats this as the conformity-vintage question: Massachusetts fixed its incorporation of the federal rules by statute, and the state's own methods, not rolling federal law, control the computation.
The liability limitations — the distinctive part
Massachusetts does not let the credit wipe out the excise. The statutory metering, as of mid-2026:
| Limitation | Effect |
|---|---|
| First $25,000 of excise | Creditable in full |
| Excise above $25,000 | Only 75% offsettable (the "75% rule") |
| Minimum excise | Cannot be reduced below the corporate minimum |
| Credit blocked by the 75% rule | Carries forward indefinitely |
| Other unused credit | Carries forward 15 years |
The two-track carryforward is unusual and taxpayer-favorable: amounts a company had but could not use because of the 75% limitation never expire, while amounts unused for other reasons run on a 15-year clock. Tracking which bucket each vintage of credit sits in is genuine work, and sloppy schedules surrender the indefinite tail. There is no carryback, no refundability, and no transfer within the research credit itself — though Massachusetts's separate life-sciences program has offered certified companies refundable credit options, a different statute with an application process and annual authorization, on which the Department of Revenue and the administering agency are the authorities.
Who benefits
The steady beneficiaries are excise-paying corporations with durable Massachusetts research operations — the biotech, robotics, and software corridor — for whom a permanent, self-serve, two-method credit is dependable annual value. The ASC-style election makes the credit accessible to newer companies without deep in-state history. Poor fits: pre-revenue companies outside the life-sciences program (nonrefundable, and the 15-year clock runs), and pass-through structures, since the credit belongs to the corporate excise world.
The trap: modeling the 75% rule as if it weren't there
The recurring error is forecasting Massachusetts benefit as rate-times-increment. Actual cash benefit in any year is bounded by $25,000 plus 75% of the excise above it, floored at the minimum tax — so a company with a $400,000 computed credit and a $200,000 excise uses far less than it accrues, and the difference lands in the (happily indefinite) carryforward rather than this year's cash flow. Multistate filers should feed the limitation into the claim-or-skip economics: Massachusetts credits are rarely lost, but they are routinely slower than the spreadsheet promises. As always, rates, methods, and limitations are as of mid-2026 and move legislatively — confirm before filing.
Frequently asked questions
- What is the Massachusetts R&D tax credit rate?
- As of mid-2026, Massachusetts allows 10% of qualified research expenses over a base amount for research in Massachusetts, and 15% for basic research payments to universities and similar institutions. Taxpayers may also elect an alternative simplified-style computation keyed to prior-year in-state spending. The credit is a permanent feature of Massachusetts law, not subject to a sunset.
- How much Massachusetts tax can the R&D credit offset?
- Not all of it. The credit offsets the first $25,000 of corporate excise in full, but only 75% of liability above that, and it cannot reduce the excise below the statutory minimum. Amounts blocked by the 75% limitation carry forward indefinitely; other unused credit amounts carry forward 15 years.
- Who can claim the Massachusetts research credit?
- Corporations subject to the Massachusetts corporate excise — including manufacturing and R&D corporations — for qualified research performed in Massachusetts, using federal Section 41 definitions. It is not refundable or transferable, so pre-profit life-sciences companies often look instead to Massachusetts's separate life-sciences incentive program, which has offered refundable credits to certified companies.